SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-070625
Filing Date
2008-03-31
Accepted
2008-03-31 13:06:14
Documents
12
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d20f.htm 20-F 1149102
2 TRANSLATION OF A LEASE dex48.htm EX-4.8 54790
3 SHARE PURCHASE AGREEMENT dex49.htm EX-4.9 143986
4 EXCLUSIVE PROMOTION SERVICE dex410.htm EX-4.10 157631
5 LIST OF SUBSIDIARIES dex81.htm EX-8.1 1352
6 CEO CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES-OXLEY ACT OF 2002 dex121.htm EX-12.1 6651
7 CFO CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES-OXLEY ACT OF 2002 dex122.htm EX-12.2 6650
8 CEO CERTIFICATION PURSUANT TO SECTION 906 OF SARBANES-OXLEY ACT OF 2002 dex131.htm EX-13.1 3709
9 CFO CERTIFICATION PURSUANT TO SECTION 906 OF SARBANES-OXLEY ACT OF 2002 dex132.htm EX-13.2 3723
10 GRAPHIC g87326g20w75.jpg GRAPHIC 31379
11 GRAPHIC g87326g24d67.jpg GRAPHIC 18416
12 GRAPHIC g87326g53e43.jpg GRAPHIC 43596
  Complete submission text file 0001193125-08-070625.txt   1658250
Mailing Address 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085
Business Address 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085 86-10-82890088
SINOVAC BIOTECH LTD (Filer) CIK: 0001084201 (see all company filings)

IRS No.: 000000000 | State of Incorp.: B9 | Fiscal Year End: 0430
Type: 20-F | Act: 34 | File No.: 001-32371 | Film No.: 08722959
SIC: 2834 Pharmaceutical Preparations